Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

5-Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD

Melissa Baker, APN, Tracy Andrews, MA, Scott D. Rowley, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Andre Goy, MD, Maria Cortes, APN, Angelica Panganiban, RN, Michele L. Donato, MD

Blood (2016) 128 (22): 3422.

https://doi.org/10.1182/blood.V128.22.3422.3422

Published: 2016

Journal Articles

Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salvage Settings

Phyllis McKiernan, APN, MSN, David S. Siegel, MD PhD, David H. Vesole, MD PhD, Tracy Andrews, MA, Scott D. Rowley, MD, Noa Biran, MD, Joshua R. Richter, MD, Andrew L. Pecora, MD, Alan P Skarbnik, MD, Andre Goy, MD, Michele L. Donato, MD

Blood (2016) 128 (22): 2302.

https://doi.org/10.1182/blood.V128.22.2302.2302

Published: 2016

Journal Articles

Venous Assessment Prior to Mobilization Significantly Reduced Use of Apheresis Central Venous Catheters

Michele Boonstra, MSN APN, Melissa Baker, APN, Tracy Andrews, MA, Maria Cortes, APN, Ann Marie Maguire, BSN, Sarina Torres, BSN, Joshua Zenreich, BS, CCRP, Lina Starovoitova, BS, CCRP, Scott D. Rowley, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Andre Goy, MD, David H. Vesole, MD PhD, Michele L. Donato, MD

Blood (2016) 128 (22): 5735.

https://doi.org/10.1182/blood.V128.22.5735.5735

Published: 2016

Journal Articles

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

Alan P Skarbnik, MD, Mary E DiLorenzo, APN, Tracy Andrews, MA, Phyllis McKiernan, APN, Scott D. Rowley, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana Feldman, MD, Lori A Leslie, MD, Lori A. Leslie, MD, Andrew L. Pecora, MD, Michele L. Donato, MD

Blood (2016) 128 (22): 5860.

https://doi.org/10.1182/blood.V128.22.5860.5860

Published: 2016

Journal Articles

Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?

James K. McCloskey, MD, Samantha Depadova, Jamie L. Koprivnikar, MD, Tracy Andrews, MA, Marshall McKenna, BA, Genique Stanislaus, ANP, Stuart L. Goldberg, MD, Stefan Faderl, MD

Blood (2016) 128 (22): 4017.

https://doi.org/10.1182/blood.V128.22.4017.4017

Published: 2016

NARROW

5-Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD

Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salvage Settings

Venous Assessment Prior to Mobilization Significantly Reduced Use of Apheresis Central Venous Catheters

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?

Email alerts

ASH Publications

American Society of Hematology

5-Day Decitabine with Mini Fludarabine and Busulfan Yields Comparable Outcomes to Mini Flu/Bu but with Increased Incidence of Severe Acute GvHD

Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salvage Settings

Venous Assessment Prior to Mobilization Significantly Reduced Use of Apheresis Central Venous Catheters

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

Features and Outcome of Patients (Pts) with New Diagnosis of Acute Myeloid Leukemia (AML) with Monocytic Differentiation (AML-Mo) Following Standard Induction Therapy. Do We Need a Different Strategy?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only